Name: Minimal Residual Disease Testing in Lymphoma
Uploaded: 2025-02-10T19:27:17Z
Duration: 32 min 9 s
Description: In this clinical science presentation, I review the publication Frank (2021)" Monitoring of circulating tumor DNA improves early relapse detection after Axicabtagene-Ciloleucel infusion in large B-call lymphoma: Results of a prospective multi-institutional trial." as support to expand testing coverage for a new clinical indication.

Webcasts